TI
ALDX icon

Trexquant Investment’s Aldeyra Therapeutics ALDX Stock Holding History

Trexquant Investment’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-158,117
Closed -$909K – 1495
2025
Q1 		$909K Buy
158,117
+43,637
+38% +$258K 0.01% 1119
2024
Q4 		$571K Buy
114,480
+102,980
+895% +$528K 0.01% 1249
2024
Q3 		$62K Buy
+11,500
New +$54.7K ﹤0.01% 1485
2023
Q4 		– Sell
-11,631
Closed -$77.7K – 1387
2023
Q3 		$77.7K Sell
11,631
-3,940
-25% -$29.2K ﹤0.01% 1401
2023
Q2 		$131K Sell
15,571
-69,762
-82% -$687K ﹤0.01% 1358
2023
Q1 		$847K Buy
85,333
+32,022
+60% +$226K 0.02% 798
2022
Q4 		$371K Buy
53,311
+33,636
+171% +$192K 0.01% 1025
2022
Q3 		$105K Buy
+19,675
New +$118K ﹤0.01% 1286
2021
Q3 		– Sell
-11,695
Closed -$133K – 1097
2021
Q2 		$133K Buy
+11,695
New +$141K 0.01% 985
2020
Q1 		– Sell
-12,304
Closed -$71K – 1064
2019
Q4 		$71K Buy
+12,304
New +$71.1K ﹤0.01% 988
2019
Q2 		– Sell
-23,407
Closed -$211K – 770
2019
Q1 		$211K Buy
+23,407
New +$199K 0.02% 854
2018
Q4 		– Sell
-38,736
Closed -$535K – 1010
2018
Q3 		$535K Buy
+38,736
New +$314K 0.04% 515

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's ALDX Position: Q2 2025 in Review

Trexquant Investment sold out of Aldeyra Therapeutics (ALDX) in Q2 2025, closing a stake of 158,117 shares — an estimated $909K sold.

Trexquant Investment first reported a position in ALDX in Q3 2018 and held it in 12 quarters. The position peaked at $909K in Q1 2025. 121 funds tracked by Wall St. Rank hold ALDX as of Q2 2025.

  • Trexquant Investment reported no remaining Aldeyra Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 158,117 Aldeyra Therapeutics shares in Q2 2025, an estimated $909K.
  • Trexquant Investment first reported a position in Aldeyra Therapeutics in Q3 2018 and held it in 12 quarters.
  • Trexquant Investment's Aldeyra Therapeutics position peaked at $909K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.